• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT GERMANY ARCHITECT HAVAB-G; HEPATITIS A VIRUS IGG ANTIBODY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT GERMANY ARCHITECT HAVAB-G; HEPATITIS A VIRUS IGG ANTIBODY Back to Search Results
Catalog Number 06L27-25
Device Problem High Test Results (2457)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Type  malfunction  
Manufacturer Narrative
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.Additional information: (b)(6) for a total of 49 samples.
 
Event Description
The customer provided results from 49 samples with results ranging from (b)(6) compared to (b)(6).There was no reported impact to patient management.The customer also sent 11-25 samples to a neighboring hospital to have them retested on an architect with havab-g lot 73145li00.There was no additional patient information provided.
 
Manufacturer Narrative
Twenty-eight potential (b)(6) samples ((b)(6) with (b)(6) hav total and (b)(6) hav igm assays) which had been tested with lot number 73336li00 or lot number 73427li00 at the customer site were sent to a neighboring hospital (b)(6) where most tested (b)(6) with lot number 73145li00.A review of the architect (b)(4) instrument logs shows high variances for (b)(6) control values with reagent lots 73336li00 and 73427li00.A review of tickets determined that there is normal complaint activity for the lot numbers and there are no trends identified for the complaint issues (specificity, sensitivity and control performance).Twenty-eight specimens were received by abbott in (b)(6) and tested with retained kits of lot numbers 73336li00 and 73427li00 and with biorad monolisatm total anti hav plus and vidas anti-hav total as reference tests.The results generated reproduced the customer's observation of (b)(6).Sensitivity and specificity testing was performed with retained kits of lot numbers 73336li00, 73427li00 (specificity and sensitivity) and 73145li00 (specificity only) and results did not indicate that the specificity or sensitivity performance of the lots is negatively impacted.Furthermore, the clinical sensitivity was evaluated by testing one commercially available seroconversion panel from biomex scp-hav-001 with lot numbers 73336li00 and 73427li00 and the lot numbers detected the same bleeds of the seroconversion panels as (b)(6) with comparable s/co values.Historical performance of the architect havab-g assay was evaluated using world wide data from abbott link.This evaluation indicated that the patient median results for lots 73336li00, 73427li00 and 73145li00 were within the established control limits and no unusual reagent performance was identified.A review of the manufacturing documentation did not identify any issues associated with the customer observation.A review of product labeling concluded that the issue was sufficiently addressed.Based on the investigation no product deficiency was identified for architect havab-g, lot numbers 73336li00, 73427li00, and 73145li00.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ARCHITECT HAVAB-G
Type of Device
HEPATITIS A VIRUS IGG ANTIBODY
Manufacturer (Section D)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM  65205
Manufacturer (Section G)
ABBOTT GERMANY
max-planck-ring 2
wiesbaden 65205
GM   65205
Manufacturer Contact
noemi romero-kondos, rn bsn
100 abbott park road
dept. 09b9, lccp1-3
abbott park, IL 60064-3537
224667-512
MDR Report Key6945315
MDR Text Key90221242
Report Number3002809144-2017-00135
Device Sequence Number1
Product Code LOL
UDI-Device Identifier00380740011185
UDI-Public00380740011185
Combination Product (y/n)N
Reporter Country CodeUS
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Health Professional
Type of Report Initial,Followup
Report Date 11/07/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/12/2017
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date07/17/2017
Device Catalogue Number06L27-25
Device Lot Number73145LI00
Was Device Available for Evaluation? Yes
Is the Reporter a Health Professional? Yes
Date Manufacturer Received11/07/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/02/2017
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage N
Patient Sequence Number1
-
-